Article
A MyCAF-Based Signature for Prognosis, Immune Landscape, and Therapeutic Response in Pancreatic Cancer
2026-03-18
Abstract excerpt
<title>Abstract</title> <p>Pancreatic ductal adenocarcinoma (PDAC) remains a highly aggressive cancer with a poor prognosis, driven in part by a complex tumor microenvironment where myofibroblastic cancer-associated fibroblasts (myCAFs) are key players. This study aimed to develop and validate a robust myCAF-related gene signature for prognostic stratification and therapeutic guidance in PAAD. Clinical and transc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 30458e89-24a5-5bb7-8376-684c97611a71
- DOI
- 10.21203/rs.3.rs-8878509/v1
